Value of Estimated Right Ventricular Filling Pressure in Predicting Cardiac Events in Chronic Pulmonary Arterial Hypertension
Hiroto Utsunomiya(Hiroshima University), Masafumi Kitakaze(Hanwa Memorial Hospital), Norifumi Nakanishi(National Cerebral and Cardiovascular Center), Satoshi Nakatani(Saiseikaisenri Hospital), Yasuki Kihara(Hiroshima University), Hideaki Kanzaki(National Cerebral and Cardiovascular Center), Shingo Kyotani(National Cerebral and Cardiovascular Center), Morikazu Nishihira(National Cerebral and Cardiovascular Center)
Cited by 42
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound
|Journal of the American Society of Echocardiography|2009|1.3k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578